AxoGen ROA 2011-2025 | AXGN
Current and historical return on assets (ROA) values for AxoGen (AXGN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| AxoGen ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.00B | $0.22B | -0.97% |
| 2025-06-30 | $-0.01B | $0.21B | -2.51% |
| 2025-03-31 | $-0.01B | $0.20B | -4.10% |
| 2024-12-31 | $-0.01B | $0.20B | -5.70% |
| 2024-09-30 | $-0.02B | $0.19B | -7.84% |
| 2024-06-30 | $-0.02B | $0.19B | -8.85% |
| 2024-03-31 | $-0.02B | $0.19B | -11.41% |
| 2023-12-31 | $-0.02B | $0.20B | -11.38% |
| 2023-09-30 | $-0.02B | $0.20B | -11.93% |
| 2023-06-30 | $-0.02B | $0.19B | -11.92% |
| 2023-03-31 | $-0.02B | $0.19B | -12.37% |
| 2022-12-31 | $-0.03B | $0.20B | -14.27% |
| 2022-09-30 | $-0.03B | $0.20B | -14.04% |
| 2022-06-30 | $-0.03B | $0.20B | -15.27% |
| 2022-03-31 | $-0.03B | $0.20B | -14.99% |
| 2021-12-31 | $-0.03B | $0.21B | -13.08% |
| 2021-09-30 | $-0.03B | $0.21B | -13.68% |
| 2021-06-30 | $-0.02B | $0.21B | -10.96% |
| 2021-03-31 | $-0.02B | $0.20B | -11.55% |
| 2020-12-31 | $-0.02B | $0.20B | -12.96% |
| 2020-09-30 | $-0.02B | $0.19B | -14.46% |
| 2020-06-30 | $-0.03B | $0.17B | -18.59% |
| 2020-03-31 | $-0.03B | $0.15B | -18.33% |
| 2019-12-31 | $-0.03B | $0.16B | -19.17% |
| 2019-09-30 | $-0.03B | $0.15B | -17.75% |
| 2019-06-30 | $-0.03B | $0.16B | -16.28% |
| 2019-03-31 | $-0.03B | $0.16B | -16.17% |
| 2018-12-31 | $-0.02B | $0.16B | -16.36% |
| 2018-09-30 | $-0.02B | $0.16B | -17.39% |
| 2018-06-30 | $-0.02B | $0.16B | -21.45% |
| 2018-03-31 | $-0.01B | $0.06B | -24.12% |
| 2017-12-31 | $-0.01B | $0.06B | -21.39% |
| 2017-09-30 | $-0.01B | $0.04B | -32.18% |
| 2017-06-30 | $-0.01B | $0.04B | -34.36% |
| 2017-03-31 | $-0.02B | $0.04B | -39.47% |
| 2016-12-31 | $-0.02B | $0.05B | -42.25% |
| 2016-09-30 | $-0.01B | $0.03B | -39.10% |
| 2016-06-30 | $-0.01B | $0.03B | -39.16% |
| 2016-03-31 | $-0.01B | $0.03B | -41.18% |
| 2015-12-31 | $-0.01B | $0.04B | -42.75% |
| 2015-09-30 | $-0.02B | $0.04B | -58.18% |
| 2015-06-30 | $-0.02B | $0.03B | -71.91% |
| 2015-03-31 | $-0.02B | $0.03B | -79.07% |
| 2014-12-31 | $-0.02B | $0.02B | -81.93% |
| 2014-09-30 | $-0.02B | $0.02B | -63.16% |
| 2014-06-30 | $-0.02B | $0.02B | -60.95% |
| 2014-03-31 | $-0.02B | $0.03B | -60.61% |
| 2013-12-31 | $-0.01B | $0.03B | -60.87% |
| 2013-09-30 | $-0.01B | $0.03B | -66.67% |
| 2013-06-30 | $-0.01B | $0.02B | -75.00% |
| 2013-03-31 | $-0.01B | $0.02B | -68.97% |
| 2012-12-31 | $-0.01B | $0.02B | -72.00% |
| 2012-09-30 | $-0.01B | $0.01B | -66.67% |
| 2012-06-30 | $-0.01B | $0.01B | -69.57% |
| 2012-03-31 | $-0.01B | $0.01B | -75.00% |
| 2011-12-31 | $-0.01B | $0.01B | -81.63% |
| 2011-09-30 | $-0.01B | $0.01B | -120.93% |
| 2011-06-30 | $-0.01B | $0.01B | -112.82% |
| 2011-03-31 | $-0.01B | $0.01B | -94.74% |
| 2010-12-31 | $-0.01B | $0.01B | -63.16% |
| 2010-09-30 | $0.01B | $0.01B | 114.29% |
| 2010-06-30 | $0.02B | $0.01B | 153.85% |
| 2010-03-31 | $0.02B | $0.01B | 206.90% |
| 2009-12-31 | $0.02B | $0.02B | 333.33% |
| 2009-09-30 | $0.00B | $0.00B | 0.00% |
| 2009-06-30 | $0.00B | $0.00B | -133.33% |
| 2009-03-31 | $0.00B | $0.00B | -133.33% |
| 2008-12-31 | $0.00B | $0.00B | -100.00% |
| 2008-09-30 | $0.00B | $0.00B | -100.00% |
| 2008-06-30 | $0.00B | $0.00B | 0.00% |
| 2008-03-31 | $0.00B | $0.00B | 0.00% |
| 2007-12-31 | $0.00B | $0.00B | 0.00% |
| 2007-09-30 | $0.00B | $0.00B | 0.00% |
| 2007-06-30 | $0.00B | $0.00B | 0.00% |
| 2007-03-31 | $0.00B | $0.00B | 0.00% |
| 2006-12-31 | $0.00B | $0.00B | 0.00% |
| 2006-09-30 | $0.00B | $0.00B | 0.00% |
| 2006-06-30 | $0.00B | $0.00B | 0.00% |
| 2006-03-31 | $0.00B | $0.00B | 0.00% |
| 2005-12-31 | $0.00B | $0.00B | -50.00% |
| 2005-09-30 | $0.00B | $0.00B | 0.00% |
| 2005-06-30 | $0.00B | $0.00B | 36.36% |
| 2005-03-31 | $0.00B | $0.00B | 36.36% |
| 2004-12-31 | $0.00B | $0.00B | 72.73% |
| 2004-09-30 | $0.00B | $0.00B | 0.00% |
| 2004-06-30 | $0.00B | $0.00B | -40.00% |
| 2004-03-31 | $0.00B | $0.00B | -36.36% |
| 2003-12-31 | $0.00B | $0.00B | -33.33% |
| 2003-09-30 | $0.00B | $0.00B | -30.77% |
| 2003-06-30 | $0.00B | $0.00B | -26.67% |
| 2003-03-31 | $0.00B | $0.00B | -47.06% |
| 2002-12-31 | $0.00B | $0.00B | -60.00% |
| 2002-09-30 | $0.00B | $0.01B | -54.55% |
| 2002-06-30 | $0.00B | $0.01B | -64.00% |
| 2002-03-31 | $0.00B | $0.01B | 0.00% |
| 2001-12-31 | $0.00B | $0.01B | 0.00% |
| 2001-09-30 | $0.00B | $0.01B | 0.00% |
| 2001-06-30 | $0.00B | $0.01B | 0.00% |
| 2001-03-31 | $0.00B | $0.01B | -50.00% |
| 2000-12-31 | $0.00B | $0.01B | -48.48% |
| 2000-09-30 | $0.00B | $0.01B | -47.06% |
| 2000-06-30 | $0.00B | $0.01B | -44.44% |
| 2000-03-31 | $0.00B | $0.01B | -42.11% |
| 1999-12-31 | $0.00B | $0.01B | -30.77% |
| 1999-09-30 | $0.00B | $0.01B | -29.27% |
| 1999-06-30 | $0.00B | $0.01B | -19.05% |
| 1999-03-31 | $0.00B | $0.01B | -9.30% |
| 1998-12-31 | $0.00B | $0.01B | -8.89% |
| 1998-09-30 | $0.00B | $0.01B | 0.00% |
| 1998-06-30 | $0.00B | $0.01B | 0.00% |
| 1998-03-31 | $0.00B | $0.01B | -8.51% |
| 1997-12-31 | $0.00B | $0.01B | -17.02% |
| 1997-09-30 | $0.00B | $0.01B | -16.67% |
| 1997-06-30 | $0.00B | $0.01B | -16.67% |
| 1997-03-31 | $0.00B | $0.01B | -8.33% |
| 1996-12-31 | $0.00B | $0.01B | 0.00% |
| 1996-09-30 | $0.00B | $0.01B | -8.16% |
| 1996-06-30 | $0.00B | $0.01B | -8.00% |
| 1996-03-31 | $0.00B | $0.01B | -7.84% |
| 1995-12-31 | $0.00B | $0.01B | -7.84% |
| 1995-09-30 | $0.00B | $0.01B | 0.00% |
| 1995-06-30 | $0.00B | $0.01B | 0.00% |
| 1995-03-31 | $0.00B | $0.01B | 0.00% |
| 1994-12-31 | $0.00B | $0.01B | 0.00% |
| 1994-09-30 | $0.00B | $0.01B | 0.00% |
| 1994-06-30 | $0.00B | $0.01B | 0.00% |
| 1994-03-31 | $0.00B | $0.01B | 0.00% |
| 1993-12-31 | $0.00B | $0.01B | 0.00% |
| 1993-09-30 | $0.00B | $0.01B | 0.00% |
| 1993-06-30 | $0.00B | $0.01B | 0.00% |
| 1993-03-31 | $0.00B | $0.01B | 0.00% |
| 1992-12-31 | $0.00B | $0.01B | 0.00% |
| 1992-09-30 | $0.00B | $0.01B | 0.00% |
| 1992-06-30 | $0.00B | $0.01B | 0.00% |
| 1992-03-31 | $0.00B | $0.01B | 0.00% |
| 1991-12-31 | $0.00B | $0.01B | 0.00% |
| 1991-09-30 | $0.00B | $0.01B | 0.00% |
| 1991-06-30 | $0.00B | $0.01B | 0.00% |
| 1991-03-31 | $0.00B | $0.01B | 0.00% |
| 1990-12-31 | $0.00B | $0.01B | 0.00% |
| 1990-09-30 | $0.00B | $0.01B | 0.00% |
| 1990-06-30 | $0.00B | $0.01B | 0.00% |
| 1990-03-31 | $0.00B | $0.06B | 0.00% |
| 1989-12-31 | $0.00B | $0.06B | 0.00% |
| 1989-09-30 | $0.00B | $0.01B | 0.00% |
| 1989-06-30 | $0.00B | $0.01B | 0.00% |
| 1989-03-31 | $0.00B | $0.01B | 0.00% |
| 1988-12-31 | $0.00B | $0.01B | 0.00% |
| 1988-09-30 | $0.00B | $0.01B | 0.00% |
| 1988-06-30 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.537B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.194B | 25.57 |
| Intuitive Surgical (ISRG) | United States | $206.246B | 80.69 |
| IDEXX Laboratories (IDXX) | United States | $57.022B | 56.63 |
| Edwards Lifesciences (EW) | United States | $50.016B | 33.54 |
| Alcon (ALC) | Switzerland | $39.820B | 26.91 |
| IQVIA Holdings (IQV) | United States | $38.462B | 21.45 |
| Mettler-Toledo (MTD) | United States | $28.903B | 33.82 |
| STERIS (STE) | Ireland | $25.840B | 26.67 |
| DexCom (DXCM) | United States | $25.542B | 35.21 |
| Waters (WAT) | United States | $23.505B | 31.09 |
| Hologic (HOLX) | United States | $16.711B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.990B | 0.00 |
| Globus Medical (GMED) | United States | $12.193B | 25.59 |
| Penumbra (PEN) | United States | $11.774B | 82.83 |
| Masimo (MASI) | United States | $7.610B | 24.39 |
| Glaukos (GKOS) | United States | $6.232B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.810B | 18.46 |
| Teleflex (TFX) | United States | $5.325B | 8.49 |
| TransMedics (TMDX) | United States | $4.665B | 55.27 |
| Veracyte (VCYT) | United States | $3.526B | 40.19 |
| LivaNova (LIVN) | United Kingdom | $3.460B | 18.69 |
| Alphatec Holdings (ATEC) | United States | $3.186B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.447B | 11.49 |
| Elekta AB (EKTAY) | Sweden | $2.210B | 20.67 |
| Artivion (AORT) | United States | $2.112B | 96.93 |
| PROCEPT BioRobotics (PRCT) | United States | $2.004B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.740B | 15.19 |
| UFP Technologies (UFPT) | United States | $1.675B | 22.11 |
| Tandem Diabetes Care (TNDM) | United States | $1.418B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.293B | 0.00 |
| IRadimed (IRMD) | United States | $1.203B | 57.32 |
| Integra LifeSciences Holdings (IART) | United States | $1.031B | 5.59 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.899B | 0.00 |
| SiBone (SIBN) | United States | $0.854B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.630B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.623B | 36.25 |
| AngioDynamics (ANGO) | United States | $0.555B | 0.00 |
| NeuroPace (NPCE) | United States | $0.546B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.523B | 10.43 |
| RxSight (RXST) | United States | $0.519B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.462B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.429B | 11.83 |
| Sight Sciences (SGHT) | United States | $0.426B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.345B | 57.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.285B | 2.13 |
| Spectral Diagnostics (EDTXF) | Canada | $0.270B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.238B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| CVRx (CVRX) | United States | $0.237B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.188B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.175B | 0.00 |
| Solana (HSDT) | United States | $0.159B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.159B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.142B | 0.00 |
| LENSAR (LNSR) | United States | $0.134B | 0.00 |
| Accuray (ARAY) | United States | $0.112B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.109B | 0.00 |
| Hyperfine (HYPR) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Neuronetics (STIM) | United States | $0.092B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.090B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.064B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.020B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.015B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.18 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |